Tata FMP - Series 61 Scheme D (91 Days)-Dir (G) - NFO
Scheme Objective
The investment objective of the scheme is to generate income and / or capital appreciation by investing in Fixed Income Instruments having maturity in line with the maturity of the scheme. The maturity of all investments shall be equal to or less than the maturity of the scheme. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The scheme does not assure or guarantee any returns.
Fund House Details
Tata Mutual Fund
| Fund Name | Rating | 3 Year CAGR | 5 Year CAGR |
|---|---|---|---|
|
Tata Small Cap Fund - Direct Growth |
5★ | 27.03% | 34.40% |
|
Tata Infrastructure Fund - Direct Growth |
3★ | 26.43% | 28.29% |
|
Tata Business Cycle Fund - Direct Growth |
0★ | 24.39% | - |
|
Tata India Pharma & Healthcare Fund - Direct Growth |
4★ | 23.72% | 29.46% |
|
Tata Equity P/E Fund - Direct Growth |
3★ | 22.55% | 21.57% |
Fund House Contact Details
FAQs
The investment objective of the scheme is to generate income and / or capital appreciation by investing in Fixed Income Instruments having maturity in line with the maturity of the scheme. The maturity of all investments shall be equal to or less than the maturity of the scheme. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The scheme does not assure or guarantee any returns.
Open date of Tata FMP - Series 61 Scheme D (91 Days)-Dir (G) 02 Dec 2024
Close date of Tata FMP - Series 61 Scheme D (91 Days)-Dir (G) 04 Dec 2024
The minimum investment amount of Tata FMP - Series 61 Scheme D (91 Days)-Dir (G) ₹5000
The Fund Manger of Tata FMP - Series 61 Scheme D (91 Days)-Dir (G) is Akhil Mittal
Mutual fund Blogs
Nifty Outlook For Tomorrow - 27 December 2024
Nifty Prediction for Tomorrow - 27th December 2024 NIFTY closed marginally up. ADANIPORTS was the t...
Unimech Aerospace IPO Allotment Status
The Unimech Aerospace IPO allotment status date is 27th December 2024. Currently, the allotment sta...
Senores Pharmaceuticals IPO Allotment Status
Summary...
